Number of Nodules, Child-Pugh Status, Margin Positivity, and Microvascular Invasion, but not Tumor Size, are Prognostic Factors of Survival after Liver Resection for Multifocal Hepatocellular Carcinoma

Journal of Gastrointestinal Surgery

Volumn 18, Issue 8, 2014, Pages 1477-1485

  Goh, Brian K P ^a,b   Chow, Pierce K H ^a,b   Teo, Jin Yao ^a   Wong, Jen San ^a   Chan, Chung Yip ^a   Cheow, Peng Chung ^a   Chung, Alexander Y F ^a   Ooi, London L P J ^a,b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

American Joint Committee for Cancer; Hepatocellular carcinoma; Multifocal; Prognosis; Staging; Survival

Indexed keywords

ADOLESCENT; ADULT; AGED; CANCER STAGING; CARCINOMA, HEPATOCELLULAR; EVALUATION STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER NEOPLASMS; LIVER RESECTION; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME; TUMOR INVASION; TUMOR VOLUME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR BURDEN; YOUNG ADULT;

EID: 84904249042     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-014-2542-0     Document Type: Article

References (25)

1. Ho CM, Huang GT, Tsang YM, et al. Liver resection improves the survival of patients with multiple hepatocellular carcinomas. Ann Surg Oncol 2009;16: 848-55.
2. Cheng CH, Lee CF, Wu TH, et al. Evaluation of the new AJCC staging system for resectable hepatocellular carcinoma. World J Surg Oncol 2011;9: 114.
3. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42: 1208-36.
4. Kim PT, Jang JH, Atenafu EG, et al. Outcomes after hepatic resection and subsequent multimodal treatment of recurrence for multifocal hepatocellular carcinoma. Br J Surg 2013;100: 1516-22.
5. Pons F, Varela M, Llovet M. Staging systems in hepatocellular carcinoma. HPB (Oxford) 2005;7: 35-41.
6. Makuuchi M, Kokudo N, Arii S, et al. Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan, Hepatol Res 2008;39: 37-51.
7. Forner A, Llover JM, Bruix J. Hepatocellular carcinoma. Lancet 2012;379: 1245-1255.
8. Torzilli G, Donadon M, Marconi M, et al. Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona clinic liver cancer classification: results of a prospective analysis. Arch Surg 2008;143: 1082-90.
9. Ishizawa T, Hasegawa K, Aoki T, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 2008;134: 1908-16.
10. Minagawa M, Ikai I, Matsuyama Y, et al. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13, 7722 patients in Japan. Ann Surg 2007;245: 909-922.
11. Ng KK, Vauthney JN, Pawlik TM, et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol 2005;12: 1-10.
12. Fan ST, Mau Lo C, Poon RT, et al. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma. Ann Surg 2011;253: 745-58.
13. American Joint Committee on Cancer. American Joint Committee on Cancer Staging Manual, 7th, Edge SB, Byrd DR, Compton CC, et al. (Eds), Springer, New York 2010: 175.
14. Choi SH, Choi GH, Kim SU, et al. Role of surgical resection for multiple hepatocellular carcinomas. World J Gastroenterol 2013;19(3): 366-74.
15. Fan ST, Poon RT, Yeung C, et al. Outcomes after partial hepatectomy for hepatocellular carcinoma within the Milan criteria. Br J Surg 2011;98: 1292-300.
16. Lim KC, Chow PK, Allen JC, et al. Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to Milan criteria. Ann Surg 2011;254: 108-13.
17. Wang JH, Changchien CS, Hu TH, et al. The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma-survival analysis of 3892 patients. Eur J Cancer 2008;44: 1000-6.
18. Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359: 378-90.
19. Zhong JH, Ke Y, Gong WF, et al. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Ann Surg 2013 in press.
20. Cheung TT, Ng KK, Chok KS, et al. Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: prognosis and outcomes. World J Gastroenterol 2010;16: 3056-62.
21. Vauthey JN, Lauwers GY, Esnaola NF, et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol 2002;20: 1527-36.
22. Vauthey JN, Klimstra D, Blumgart LH. A simplified staging system for hepatocellular carcinomas. Gastroenterology 1995;108: 617-8.
23. Huang J, Zhang Y, Peng Z, et al. A modified TNM-7 staging system to better predict the survival in patients with hepatocellular carcinoma after hepatectomy. J Cancer Res Clin Oncol 2013;139: 1709-19.
24. Tsai TJ, Chau GY, Lui WY, et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000;127: 603-8.
25. Fong Y, Sun RL, Jarnagin W, et al. An analysis of 412 cases of hepatocellular carcinoma at a western center. Ann Surg 1998;229: 790-800.